Possible fifth case of brain infection linked to Tysabri

Share this article:
A possible fifth case of a rare and deadly brain infection linked to the multiple sclerosis (MS) drug Tysabri has been reported to federal regulators, The Wall Street Journal reported today.
The case was reported May 16 through the FDA's Adverse Event Reporting System, which collects reports of possible drug reactions from doctors and drug makers.
An FDA spokeswoman told the newspaper that these reports don't represent confirmed cases.
The fifth possible case was reported by an unnamed health professional and concerns a female patient whose age is undisclosed. No other details of her condition were available, the newspaper report said.
Share this article:

Email Newsletters

More in Business Briefs

Novartis apologizes for slow reporting

Novartis is apologizing to Japan after the Ministry of Health, Labor and Welfare said the company had dragged its feet reporting adverse events for two of its cancer drugs.

J&J pulls morcellator from market

The company is calling the move a withdrawal, as opposed to a recall.

Pfizer buys two Baxter vaccines

The meningitis and encephalitis medications earned a combined $300 million last year.